Lymphomas

Lymphoma is a cancer of the lymphatic tissue (lymphatic system), which plays a major role in activating our immune system. It is characterized by the formation of solid tumors in the immune system.1 This type of cancer affects immune cells called lymphocytes, which are a type of white blood cell.

LifEscozul™ - Lymphomas

A lymphoma is a malignant proliferation of lymphocytes (immune system cells), in other words lymphatic tissue, usually within the lymph nodes, although it can affect other tissues.

Lymphoma affects between three and six people per 100,000 inhabitants each year. The average age at which the disease usually appears is 60 years. The treatment of lymphoma depends on the prognosis, age and general condition of the patient, as well as the type of lymphoma, among others.

There are two main types of lymphoma: Hodgkin's lymphoma or Hodgkin's disease. All other types of lymphoma are called non-Hodgkin's lymphoma. Once the type of lymphoma is determined, it is classified according to its prognosis by grades: low, intermediate and high.

The main treatments available are chemotherapy, radiotherapy, immunotherapy and bone marrow transplantation, when possible.

Escozul™ can be administered in conjunction with any conventional treatment. Escozul™ seeks to work not only on the cancer but also on the patient's quality of life. Its analgesic and anti-inflammatory effects help to improve the quality of life in about 65 to 75% of the patients treated. Through its antitumor effect, depending on the stage, one of the following results is expected: to be able to slow down the progression of the disease, to stop tumor growth, to reduce the size of lesions or to eliminate tumor lesions.

It is important to point out that Escozul™ is not considered a cure for cancer, it is a natural medicine that converts this deadly disease into a controlled chronic one, also offering quality of life.

Results in different cases

Recurrent non-Hodgkin's lymphoma. Patient: Natali Age: 29

Patient with recurrent non-Hodgkin's lymphoma with cervical and bilateral intraparotid lymph node involvement, in natural treatments, manages to eliminate the disease just over a year after starting with Escozul™.

Natali is a 28 year old patient, who came to us in June 2016 with a diagnosis of Non-Hodgkin's Lymphoma, second onset, with cervical and intraparotid lymph node involvement. Natali had never undergone conventional treatments. After 13 months on treatment with Escozul™ in conjunction with other natural therapies, Natali's tests indicate NO presence of the disease.

Summary of the case:

We share the case Natali, 29 years old, who came to us in June 2016, with a diagnosis of recurrent Non-Hodgkin's Lymphoma, with a first appearance in 2014.

When we received the medical documentation we were able to ascertain that Natali a relapse of Non-Hodgkin's Lymphoma, with involvement of right submandibular lymph nodes (lymphadenopathies up to 26mm), in right parotid with lymphadenopathies up to 18mm and in left with lymphadenopathies up to 4.6mm. There was also involvement of jugular and right posterior cervical nodes and in the left submandibular region.

Once the case was analyzed by our specialists, we informed Natali what she could expect with Escozul™ and the possibilities of achieving good results.

Each dose of Escozul™ is personalized, specific to the type of tumor and its aggressiveness. These doses can change over time according to the results observed in the patient. This requires an effective communication between the patient and our medical team to allow us to make the appropriate recommendations on different aspects. If the patient or family members do not maintain fluid communication with us, then the results with Escozul™ will not be as expected.

Natali started treatment with Escozul™ at the end of June 2016, she was performing other natural treatments such as Kambó and later administration of enriched plasma and proper nutrition.

Evolution, Follow-up and Current Results:

Natali is a very positive person, eager to live and move forward and very determined. She always focused on finding natural options to fight the disease, looking for treatments that would help her strengthen her immune system, such as Kambó and plasma injections; and Escozul™, which directly attacks the tumor cells.

Natali's evolution has been satisfactory, showing improvement since the first examinations, with a progressive decrease in the size of the lesions.

Finally, in the last CT scan performed, dated December 2017, no presence of the disease was observed at any level, all the tumor lesions have disappeared, so Natali has passed to the surveillance phase, although she will remain on Escozul™ for a few more months in order to consolidate these results.

In this case, with the use of Escozul™ in conjunction with other natural treatments, it has been possible to gradually reduce the disease until all tumor involvement in the body has been eliminated.

As we always say, it is important to note that it is not possible to generalize any results with Escozul™ to avoid creating false expectations in people, Escozul™ does not work miracles. Only working together and constant communication allow to keep the doses of Escozul™ personalized and functional against tumors.

It is also important to say that all the medical information of the case is available for consultation, as well as the contact with the medical counterpart of both the oncologist who attended the case and our specialists. We believe in transparency in dealing with our patients and the right to form an opinion based on information and analysis.

If you wish to be treated under the Escozul™ Protocol, you should know the following: Escozul™ is a product that we are still investigating, including its other properties such as analgesic and anti-inflammatory, therefore it is not a commercial product, i.e. it cannot be sold. Each case that wishes to enter our protocol must be evaluated and approved because Escozul™ is not effective in all types of tumors. Once approved, the patient and his family members must commit to maintain a fluid contact with our medical team.

To enter the protocol you must send us an email to: servicios@lifescozulcuba.com indicating the patient's age, the type of cancer and the patient's physical and emotional state. This is the first step, and a specialist will take charge of the case. Our response time is an hour or two because each case is answered personally, not automatically. The idea is that the communication we establish is always governed by a professional and humane treatment.

Prepared by LifEscozul™ Group January/2018

Medical Documents

LifEscozul™ - Natali 1 - Linfómas
LifEscozul™ - Natali 2 - Linfómas
LifEscozul™ - Natali 3 - Linfómas
LifEscozul™ - Natali 4 - Linfómas

Relapsed non-Hodgkin's lymphoma. Patient: Amada Age: 62

Patient with non-Hodgkin's lymphoma of first appearance in 2010, treated with chemotherapy and radiotherapies, who presented abdominal relapse in 2016. After 6 months of treatment with Escozul™ she presents reduction of the disease.

Amada is a 62-year-old patient, who was diagnosed with Non-Hodgkin's Lymphoma in 2010, successfully treated with conventional medicine. She came to us in November 2016 with a relapse of the lymphoma with abdomino pelvic lymphoproliferative abdomino pelvic involvement.

Case summary:

We share today the case of a 62-year-old patient who came to us in November 2016 with a diagnosis of relapsed abdomino-pelvic non-Hodgkin's lymphoma.

When we received the medical documentation we were able to ascertain that Amada had had non-Hodgkin's lymphoma for the first time in 2010, which was successfully treated in 2010 with chiasis and radiotherapy. In 2016 she presented relapse with lymph node involvement in right common iliac conglomerate in adenopathies between 16 and 18mm; in right external iliac chain with adenopathies between 16 and 19mm; right obturator chain with adenopathies up to 9mm, and right internal gluteal chain with adenopathies up to 12mm.

As for symptoms, she presented abdominal pain on the right side, night sweats, difficulty with feeding, anemia, depression, cough and fever.

Once the case was analyzed by our specialists, we informed the patient about what to expect with Escozul™ and the possibilities of achieving good results.

Each dose of Escozul™ is personalized, specific to the type of tumor and its aggressiveness. These doses can change over time according to the results observed in the patient. This requires an effective communication between the patient and our medical team to allow us to make the appropriate recommendations on different aspects. If the patient or family members do not maintain fluid communication with us, then the results with Escozul™ will not be as expected.

Amada started treatment with Escozul™ in November 2016. She was pending to start chemotherapy.

Evolution, Follow-up and Current Results:

During the time of treatment with Escozul™, Amada felt much better physically remitting most of her symptoms, although you asked for anemia. In the new CT scan that we received dated May 23, 2017, 6 months after starting with Escozul™, the ganglionic conglomerates described at the infradiaphragmatic level have disappeared, at the moment there are scattered retroperitoneal adenopathies of origin to be determined, without being able to rule out that despite not being in conglomerates, they correspond to a lymphoproliferative process.

At this moment Amada continues to be treated with Escozul™ with increasing doses, seeking to improve the results obtained.

In this case it has been achieved, in conjunction with the use of chemotherapy, has helped Amada to improve her physical condition and outlook for the disease.

As we always say, it is important to point out that it is not possible to generalize any results with Escozul™ to avoid creating false expectations in people, Escozul™ does not work miracles. Only working together and constant communication allow to keep the doses of Escozul™ personalized and functional against tumors.

It is also important to say that all the medical information of the case is available for consultation, as well as the contact with the medical counterpart of both the oncologist who attended the case and our specialists. We believe in transparency in dealing with our patients and the right to form an opinion based on information and analysis.

If you wish to be treated under the Escozul™ Protocol, you should know the following: Escozul™ is a product that we are still investigating, including its other properties such as analgesic and anti-inflammatory, therefore it is not a commercial product, that is, it cannot be sold. Each case that wishes to enter our protocol must be evaluated and approved because Escozul™ is not effective in all types of tumors. Once approved, the patient and his family members must commit to maintain a fluid contact with our medical team.

To enter the protocol you must send us an email to: servicios@lifescozulcuba.com indicating the patient's age, the type of cancer and the patient's physical and emotional state. This is the first step, and a specialist will take charge of the case. Our response time is an hour or two because each case is answered personally, not automatically. The idea is that the communication we establish is always governed by a professional and humane treatment.

Prepared by LifEscozul™ Group May/2017

Medical Documents

LifEscozul™ - Amada 1 - Linfómas
LifEscozul™ - Amada 2 - Linfómas

F.E. Diffuse large B-cell non-Hodgkin's lymphoma, age: 17 years.

Patient with mediastinal lymphoma achieves regression of the disease, in joint treatment with Escozul™ and chemotherapy.

Patient Data:

Initials: F. E (name not shared because she is a minor) Age: 17.

Initial Diagnosis:

Diffuse large B-cell non-Hodgkin's lymphoma in anterior mediastinum (size 11×7.5cm), displacing right cardiac cavities.

Initial symptoms:

Weight loss, Difficulty sleeping, Dyspnea at rest, Irritability.

Treatments:

Started on Escozul™ in mid-July 2015. Patient was undergoing chemotherapy (2 of 8 planned), to be followed by radiation therapy.

It is important to remember that Escozul™ is a natural product that has the ability to eliminate tumor cells, without meaning that it is a cure for cancer. Its ability to inhibit malignant cell growth allows it to be used as a disease controller and the work approach is carried out seeking that the patient can live with his disease with the least possible affectation to his daily routine.

Evolution and current results:

From the first reports there were noticeable improvements: she began to sleep better and her appetite improved. One month after treatment, the patient began to regain weight and her relatives reported that she looked better.

In the control carried out at the beginning of October, 3 months after starting treatment with Escozul™, and still without concluding the chemotherapy cycles (5th cycle), a tomography was included, in which the presence of the tumor was NOT observed. Blood tests showed normal values, and the patient recovered her initial weight.

The patient is currently stable and has no symptoms related to the disease.

In this case, with the combined application of Escozul™ and chemotherapy, it has been possible not only to eliminate the disease, but also to help the patient improve her physical condition and quality of life, from the first doses of Escozul™.

It is important to point out that it is not possible to generalize any result with Escozul™ in order to avoid creating false expectations in people. Each case we receive is analyzed in order to inform the family what to expect. Each person is a completely different universe, even if they have the same disease. This document is not a testimony but a summary of evolution where medical information is available for consultation.

Medical Documents

LifEscozul™ - F.E. 1 - Linfómas
LifEscozul™ - F.E. 2 - Linfómas
LifEscozul™ - F.E. 3 - Linfómas
LifEscozul™ - F.E. 4 - Linfómas